A Randomized Controlled Study of Docetaxel Monotherapy or Docetaxel and DOXIL for the Treatment of Advanced Breast Cancer

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-000617-19

Femme Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is to evaluate whether the overall survival for the DOXIL/CAELYX and docetaxel treatment group is superior to that of the group treated with docetaxel monotherapy


Critère d'inclusion

  • Breast Cancer